174 related articles for article (PubMed ID: 7489414)
1. Vitamin D receptor genotypes in primary hyperparathyroidism.
Carling T; Kindmark A; Hellman P; Lundgren E; Ljunghall S; Rastad J; Akerström G; Melhus H
Nat Med; 1995 Dec; 1(12):1309-11. PubMed ID: 7489414
[TBL] [Abstract][Full Text] [Related]
2. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
3. The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels.
Correa P; Rastad J; Schwarz P; Westin G; Kindmark A; Lundgren E; Akerström G; Carling T
J Clin Endocrinol Metab; 1999 May; 84(5):1690-4. PubMed ID: 10323401
[TBL] [Abstract][Full Text] [Related]
4. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor gene polymorphism and parathyroid calcium sensor protein (CAS/gp330) expression in primary hyperparathyroidism.
Carling T; Ridefelt P; Hellman P; Juhlin C; Lundgren E; Akerström G; Rastad J
World J Surg; 1998 Jul; 22(7):700-6; discussion 706-7. PubMed ID: 9606285
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and the parathyroid.
Beckerman P; Silver J
Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
[TBL] [Abstract][Full Text] [Related]
7. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
Russell J; Bar A; Sherwood LM; Hurwitz S
Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
[TBL] [Abstract][Full Text] [Related]
8. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
9. The distribution of two different vitamin D receptor polymorphisms (BsmI and start codon) in primary hyperparathyroidism.
Sosa M; Torres A; Martín N; Salido E; Limiñana JM; Barrios Y; De Miguel E; Betancor P
J Intern Med; 2000 Jan; 247(1):124-30. PubMed ID: 10672140
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
Buchwald PC; Westin G; Akerström G
Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
[TBL] [Abstract][Full Text] [Related]
12. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
McCann LM; Beto J
J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
[TBL] [Abstract][Full Text] [Related]
13. Influence of Bsml vitamin D receptor gene polymorphism on the response to a single bolus of calcitrol in hemodialysis patients.
Marco MP; Martínez I; Betriu A; Craver L; Fibla MJ; Fernández E
Clin Nephrol; 2001 Aug; 56(2):111-6. PubMed ID: 11522087
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.
Carling T; Ridefelt P; Hellman P; Rastad J; Akerström G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1772-5. PubMed ID: 9177380
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D
Lee SM; Pike JW
J Steroid Biochem Mol Biol; 2016 Nov; 164():265-270. PubMed ID: 26323657
[TBL] [Abstract][Full Text] [Related]
16. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
Segersten U; Björklund P; Hellman P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor gene polymorphism detected by digestion with Apa I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients.
Yokoyama K; Shigematsu T; Kagami S; Tsukada T; Arai T; Hara S; Yamada A; Kawaguchi Y; Hosoya T
Nephron; 2001 Nov; 89(3):315-20. PubMed ID: 11598396
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.
Carling T; Rastad J; Akerström G; Westin G
J Clin Endocrinol Metab; 1998 Jul; 83(7):2255-9. PubMed ID: 9661591
[TBL] [Abstract][Full Text] [Related]
19. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
[TBL] [Abstract][Full Text] [Related]
20. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease.
Yokoyama K; Shigematsu T; Tsukada T; Ogura Y; Takemoto F; Hara S; Yamada A; Kawaguchi Y; Hosoya T
Kidney Int; 1998 Feb; 53(2):454-8. PubMed ID: 9461106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
